Clinical trial Recruiting at 1 site Observational

Network for understanding Bipolar Disorder in Norway

Official title: Bipolar Research And Innovation Network - BRAIN

Run by Norwegian University of Science and Technology · NCT00201526 · Data updated 2026-11-12

This study looks at different types of people with Bipolar Disorder in Norway to see how they are doing over time and what factors might affect their health.

Quick facts

Study typeObservational
SexAll
Enrollment3000 (estimated)
SponsorNorwegian University of Science and Technology
Academic / other
Locations1 site (Trondheim)
StatusRecruiting
StartedJanuary 2003
Main results expectedJanuary 2030
Study endsJanuary 2030
Registry record updatedDecember 12, 2025
Trial IDNCT00201526 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are all patients diagnosed with Bipolar Disorder who are admitted to psychiatric care and can provide written consent.

Probably not a fit

Patients who lack the capacity to provide consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to describe the diverse range of patients with Bipolar Disorder admitted to both outpatient and inpatient psychiatric departments across Norway. It includes all bipolar patients, regardless of the presence of co-morbid disorders, and utilizes a comprehensive approach involving clinical evaluations, imaging studies (CT or MRI), EEGs, and blood sample collection for genetic mapping. The study leverages Norway's homogeneous society and public health system to track patient outcomes over several years.

Why it matters

Potential benefit: If successful, this study could enhance understanding of Bipolar Disorder and improve treatment strategies for patients.

How similar studies have gone: Other studies focusing on the characterization of Bipolar Disorder have shown success in understanding the condition, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All admitted patients giving written consent to participate in the study

Exclusion Criteria:

* Patients without competence for consent.

Where it's running

  • Medical Faculty, Norwegian University of Science And Technology
    Trondheim, Norway
    Recruiting

Study contacts

  • Principal investigator: Gunnar Morken, PhD MD — Norwegian University of Science and Technology
  • Study coordinator: Arne Vaaler, PhD MD
  • Email: arne.e.vaaler@ntnu.no
  • Phone: +47 92090415

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.